Roche Merges Japanese Subsidiary with Chugai | GenomeWeb

NEW YORK, Dec. 10 – Swiss pharmaceutical company Roche said Monday it was merging its Nippon Roche subsidiary with Japanese pharmaceutical company Chugai in a new entity that will be named Chugai Pharmaceutical. 

Chugai chairman and CEO, Osamu Nagayama, will be the chairman and CEO of the merged company. Wataru Ogawa, Nippon Roche’s current president and CEO, will be nominated for a seat on the board of directors. Roche will hold 50.1 percent of the company’s shares.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.